欧洲疾控中心：2024年白假丝酵母（白念珠菌）流行病学情况、实验室能力及应对准备调查报告（英文版）

Candidozyma auris (formerly Candida auris) poses a risk for patients in healthcare facilities across Europe due to its ability to cause severe infections in critically ill patients, its potential resistance to several antifungal agents, which makes infections difficult to treat, and its propensity for transmission and outbreaks in healthcare settings. The C. auris survey 2024 shows that spread of C. auris continues to occur at a rapid pace. In total, 4 012 cases of C. auris colonisation or in